Key result
Resecting a giant RV intimal sarcoma triggers severe postoperative coagulopathy, systemic inflammation, and malignant arrhythmias.
Why the study?
The impact of foreign tumor fragments entering the bloodstream on contact activation, coagulopathy, and systemic inflammatory response syndrome during surgical resection of rare primary malignant cardiac tumors under CPB remains difficult to predict.
Case Report (n=1)
No
Resection of intracardiac malignant tumors under cardiopulmonary bypass carries a high risk of severe contact activation, leading to severe coagulopathy and systemic inflammation, which requires comprehensive anti-inflammatory measures and point-of-care coagulation monitoring.
Answers are grounded in this paper and cite their sources.
Highlights risks of coagulopathy and inflammation after intracardiac tumor resection; leaves open optimal perioperative protocols.
BACKGROUND: Primary malignant cardiac tumors are rare in clinic, and surgical resection under cardiopulmonary bypass (CPB) remains the main treatment. The non-physiological perfusion process of CPB leads to contact activation, and the resulting coagulopathy and systemic inflammatory response syndrome (SIRS) are common complications. However, it is difficult to predict the impact of foreign tumor fragments on this pathophysiological process once they enter the bloodstream, making this phenomenon more complex and challenging. CASE PRESENTATION: We report a case of cardiac intimal sarcoma who developed severe coagulopathy and widespread inflammation after excision of massive right ventricular tumor and replacement of tricuspid valve by median sternotomy under CPB. Although the procedure was expected to cause tumor cell necrosis and precautions were taken, uncontrolled massive postoperative bleeding, persistent fever, abnormally elevated inflammatory markers, and recurrent malignant arrhythmias occurred after surgery. In addition to common factors, the most possible underlying mechanism is contact activation triggered following surgical procedure for intimal sarcoma with CPB. CONCLUSION: Patients with intracardiac malignant tumors are at a high risk for serious contact activation during CPB. Preventive application of comprehensive anti-inflammatory measures such as drugs and adsorptive CPB technology, as well as point-of-care (POC) monitoring of coagulation status will be helpful for individualized guidance and optimization of CPB management, and improvement of patient prognosis.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) conducted a case report in Right ventricular intimal sarcoma (n=1). Surgical resection with cardiopulmonary bypass was evaluated. Surgical resection of a giant right ventricular intimal sarcoma under cardiopulmonary bypass in a 43-year-old male resulted in severe postoperative coagulopathy, systemic inflammation, and malignant arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: